Article Details

Alnylam Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent ...

Retrieved on: 2021-04-29 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Alnylam Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent .... View article details on hiswai:

Excerpt

*Excludes $160-$180 million of stock-based compensation expenses from ... expenses and unrealized gains on marketable equity securities.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo